Stockle - the stock oracle

Apotheca Biosciences, Inc.

US:PCFPUS:CBDC
No current share price held for this company.

Past year: ▼ 98%(0.01c – 7.00c USD)

Market cap
—
Shares on issue
—
Story beats
14 since 2017
Last event
27 June 2019

Announcements, explained

Each one in plain English, with the numbers worked through for a shareholder.

27 June 2019material agreement● NeutralMajor

Took an exclusive licence to sell CB Scientific's Test4 cannabis test kits under its ProMED brand, paying a 30-40% royalty on every kit. The third deal announced in a month, and the only one with an actual product attached; six weeks later the company stopped filing altogether.

Discuss in chat

21 June 2019material agreement▼ BadMajor

Two weeks later, a second agreement-to-agree: 51% of Hemp Bloom LLC and its 600 acres in Colorado and Oregon, with the filing projecting $38 million of CBD or $182 million of CBG revenue by 2020 while conceding it might not be able to farm the land at all. Nothing further was ever filed about it.

Discuss in chat

5 June 2019material agreement▼ BadMajor

Announced it had "agreed to come to a definitive agreement" to buy 51% of Hemp Sciences Corp for 60 million shares valued at six cents each, doubling the share count for a business that is a division of Nuvus Corp - one of the related parties that had been lending the company its operating cash. No definitive agreement or completion was ever filed.

Discuss in chat

14 Dec 2018other material event● NeutralMajor

The Florida circuit court gave the company what it asked for: an order finding it was not and never had been a shell company, freeing shareholders to sell under Rule 144. The company's own history - incorporated to explore minerals, never mining, then licensing, then a reverse takeover - is exactly the shape the shell definition exists to catch.

Discuss in chat

29 Nov 2018other material event● NeutralMajor

Sued in a Florida state court for a declaration that it had never been a "shell" company, after a broker's lawyer told shareholders it had been - which would block them from selling under Rule 144. A company asking a county court to settle a federal securities-law question about its own past.

Discuss in chat

31 Aug 2018business combination● NeutralMajor

Filed the full disclosure record for the Apotheca takeover, which had actually closed on 6 March 2018 and been announced by press release in June - roughly six months before this filing. The company moved to St Petersburg, Florida, said it had no revenue and a going-concern problem, and disclosed that its cash had come from small related-party loans; chairman Sam Talari is described as holding about 68% of the votes.

Discuss in chat

7 May 2018material agreement termination▼ BadMajor

Walked away from both Washington deals at once: the Affordable Green licence was settled and cancelled for 2.6 million restricted shares, and the Green Venture / MMS Farms letter of intent was terminated with nothing ever paid. Fourteen months and a string of small payments produced no business, and the shares came out of shareholders' pockets.

Discuss in chat

9 Mar 2018business combination● NeutralMajor

Agreed to hand 60 million new shares - about 60% of the enlarged company - to the owners of a private Florida business called Apotheca Biosciences, which would take the board, the officers and the name. A reverse takeover: the Washington cannabis-licensing plan was being replaced wholesale by a CBD products venture.

Discuss in chat

18 Dec 2017auditor change▼ Bad

Dismissed auditor TAAD LLP, which had put a going-concern warning on both of the company's audited years because it needed money simply to service its debt. No replacement auditor was named in the filing.

Discuss in chat

2 Nov 2017material agreement● NeutralMajor

Signed a second letter of intent, this time to take over Green Venture Capital's own letter of intent with MMS Farms, a licensed Washington marijuana grower, for $500,000 payable in instalments. A deal to buy a right to a deal - and still four months behind on the first licence it signed.

Discuss in chat

7 Aug 2017material agreement▼ BadMajor

Chief executive Jason Sakowski bought 27 million restricted shares from the company's former directors and officers for a combined $15,000, taking control outright. Control of a listed company changed hands for the price of a used car, with payment not due until March 2018.

Discuss in chat

31 July 2017material agreement▼ BadMajor

Rewrote the Affordable Green licence again, raising the total owed to $2.3 million while the payment schedule showed what had actually been paid: $25,000, then $9,800, $15,200, $10,000 and $10,000. The company was meeting a multi-million-dollar commitment in five-figure instalments.

Discuss in chat

22 June 2017bylaws amendment● NeutralMajor

Renamed itself Cannabis Leaf Incorporated by merging a shell subsidiary of that name into itself - a paperwork device that needed no shareholder vote - and at the same time multiplied its shares six-for-one and raised its authorised capital. The mineral-exploration identity was formally dropped for a cannabis one.

Discuss in chat

9 May 2017material agreement● NeutralMajor

Converted the March letter of intent into a definitive exclusive licence with Affordable Green Washington, due $25,000 on signing, $100,000 by end of May and $2 million by 30 September 2017. Director Wan Soo Lee resigned the same day.

Discuss in chat

4 Apr 2017material agreement● NeutralMajor

Pacificorp Holdings - a Nevada shell incorporated in 2014 to explore mineral properties, with no mining ever done - signed a letter of intent to license Affordable Green Washington's marijuana products and marketing model for Washington State, promising $2.1 million in stages. The first move in a three-year hunt for a business to be in.

Discuss in chat